PRNewswire Asia

Taiwan aims to create pandemic prevention product ecosystem

TAIPEI, May 5, 2020 /PRNewswire/ -- An ecosystem of pandemic prevention products and related industries has already been formed in Taiwan, aimed at offering assistance in the fight against the raging COVID-19 outbreak, a TAITRA representative said on Monday....

Tessa Therapeutics Announces New Executive Leadership

SINGAPORE, May 5, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced that Jeffrey H. Buchalter will assume the role of Chief Executive Officer, and Göran A....

Kavalan creates entry-level range to capture broad market

Series promises signature quality at a good price TAIPEI, Taiwan, May 4, 2020 /PRNewswire/ -- Not content with one entry-level whisky, Kavalan has now announced the creation of a new entry-level range as part of its portfolio alongside existing Kavalan series like...

INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference

- INO-4700 (GLS-5300) DNA vaccine demonstrates 100% binding and 92% neutralizing antibody responses against MERS-CoV - INO-4800 DNA vaccine for COVID-19 currently in Phase 1 trial utilizes identical strategy targeting Spike protein and CELLECTRA intradermal delivery...

Azeus: Ensure Business Continuity with Convene

HONG KONG, April 27, 2020 /PRNewswire/ -- As a response to the COVID-19 pandemic, Azeus announces that Convene, the multi-awarded end-to-end digital meeting management solution, is offering 6-month use to organizations all over the world. This is Azeus' way of...

Introducing MedsLOCK by Maxonrow and Avantas Tech

A Monitoring and Communication App that Provides Real-Time COVID-19 Insights SINGAPORE, April 27, 2020 /PRNewswire/ -- Maxonrow is honored to team up with Avantas Tech to launch MedsLOCK, a much-welcomed solution to help combat the global flight against COVID-19....

New Early Breast Cancer Drug Available Now In Singapore

NERLYNX® (neratinib) now commercially available in Singapore for HER2+ breast cancer patients following adjuvant trastuzumab-based therapy Five-year follow up data show NERLYNX reduces risk of invasive disease recurrence by 42% in women with early-stage, HER2+/HR+...